205 related articles for article (PubMed ID: 29843776)
1. Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients.
Druce KL; Aikman L; Dilleen M; Burden A; Szczypa P; Basu N
Arthritis Res Ther; 2018 May; 20(1):96. PubMed ID: 29843776
[TBL] [Abstract][Full Text] [Related]
2. Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
Gwinnutt JM; Leggett S; Lunt M; Barton A; Hyrich KL; Walker-Bone K; Verstappen SMM;
Rheumatology (Oxford); 2020 Oct; 59(10):2908-2919. PubMed ID: 32097471
[TBL] [Abstract][Full Text] [Related]
3. Contextual factors influence work outcomes in employed patients with ankylosing spondylitis starting etanercept: 2-year results from AS@Work.
Boonen A; Boone C; Albert A; Mielants H
Rheumatology (Oxford); 2018 May; 57(5):791-797. PubMed ID: 29373701
[TBL] [Abstract][Full Text] [Related]
4. Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity.
Smolen JS; Strand V; Koenig AS; Szumski A; Kotak S; Jones TV
Arthritis Res Ther; 2016 May; 18(1):114. PubMed ID: 27209012
[TBL] [Abstract][Full Text] [Related]
5. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
[TBL] [Abstract][Full Text] [Related]
6. Fatigue contributes to work productivity impairment in patients with axial spondyloarthritis: a cross-sectional UK study.
Espahbodi S; Bassett P; Cavill C; Freeth M; Hole J; Sengupta R
Clin Exp Rheumatol; 2017; 35(4):571-578. PubMed ID: 28240589
[TBL] [Abstract][Full Text] [Related]
7. Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort.
Claudepierre P; Van den Bosch F; Sarzi-Puttini P; Vastesaeger N; Govoni M; Kachroo S
Int J Rheum Dis; 2019 Jun; 22(6):995-1001. PubMed ID: 30989813
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.
Bansback N; Zhang W; Walsh D; Kiely P; Williams R; Guh D; Anis A; Young A
Rheumatology (Oxford); 2012 Feb; 51(2):375-84. PubMed ID: 22179728
[TBL] [Abstract][Full Text] [Related]
9. Reasons for Discontinuation and Adverse Effects of TNFα Inhibitors in a Cohort of Patients With Rheumatoid Arthritis and Ankylosing Spondylitis.
García-Lagunar MH; Gutiérrez-Cívicos MR; García-Simón MS; Conesa-Zamora P; Jimenez-Santos E; Cano-Vivar P; García-Márquez A; Muñoz-García I; Viney AC
Ann Pharmacother; 2017 May; 51(5):388-393. PubMed ID: 27920336
[TBL] [Abstract][Full Text] [Related]
10. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL.
Fafá BP; Louzada-Junior P; Titton DC; Zandonade E; Ranza R; Laurindo I; Peçanha P; Ranzolin A; Hayata AL; Duarte A; Silveira IG; Costa I; Macieira JC; Guedes-Barbosa LS; Bertolo MB; Sauma MF; Silva MB; Freire M; Scheinberg MA; Fernandes V; Bianchi W; Miranda JR; Pinheiro GR; Carvalho HM; Brenol CV; Pereira IA; de Castro GR; de Morais JC; Oliveira SK; de Abreu MM; Toledo RA; Pinheiro MM; Vieira WP; Valim V;
Clin Rheumatol; 2015 May; 34(5):921-7. PubMed ID: 25851594
[TBL] [Abstract][Full Text] [Related]
11. Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis.
Rudwaleit M; Mørup MF; Humphries B; Zannat NE; Willems D; Taieb V; Boonen A
RMD Open; 2023 Nov; 9(4):. PubMed ID: 38035757
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.
Verstappen SM
Best Pract Res Clin Rheumatol; 2015 Jun; 29(3):495-511. PubMed ID: 26612244
[TBL] [Abstract][Full Text] [Related]
13. Burden of rheumatoid arthritis on patients' work productivity and quality of life.
Xavier RM; Zerbini CAF; Pollak DF; Morales-Torres JLA; Chalem P; Restrepo JFM; Duhau JA; Amado JR; Abello M; de la Vega MC; Dávila AP; Biegun PM; Arruda MS; Ramos-Remus C
Adv Rheumatol; 2019 Nov; 59(1):47. PubMed ID: 31706348
[TBL] [Abstract][Full Text] [Related]
14. Productivity loss of Japanese patients with rheumatoid arthritis - A cross-sectional survey.
Sruamsiri R; Mahlich J; Tanaka E; Yamanaka H
Mod Rheumatol; 2018 May; 28(3):482-489. PubMed ID: 28849715
[TBL] [Abstract][Full Text] [Related]
15. Real-life 10-year retention rate of first-line anti-TNF drugs for inflammatory arthritides in adult- and juvenile-onset populations: similarities and differences.
Favalli EG; Pontikaki I; Becciolini A; Biggioggero M; Ughi N; Romano M; Crotti C; Gattinara M; Gerloni V; Marchesoni A; Meroni PL
Clin Rheumatol; 2017 Aug; 36(8):1747-1755. PubMed ID: 28597133
[TBL] [Abstract][Full Text] [Related]
16. Identifying Persons with Axial Spondyloarthritis At Risk of Poor Work Outcome: Results from the British Society for Rheumatology Biologics Register.
Macfarlane GJ; Shim J; Jones GT; Walker-Bone K; Pathan E; Dean LE
J Rheumatol; 2019 Feb; 46(2):145-152. PubMed ID: 30385702
[TBL] [Abstract][Full Text] [Related]
17. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
[TBL] [Abstract][Full Text] [Related]
18. Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study.
Tanaka Y; Yamazaki K; Nakajima R; Komatsu S; Igarashi A; Tango T; Takeuchi T
Mod Rheumatol; 2018 Jan; 28(1):39-47. PubMed ID: 28704126
[TBL] [Abstract][Full Text] [Related]
19. Anti-nuclear antibodies, anti-DNA and C4 complement evolution in rheumatoid arthritis and ankylosing spondylitis treated with TNF-alpha blockers.
Gonnet-Gracia C; Barnetche T; Richez C; Blanco P; Dehais J; Schaeverbeke T
Clin Exp Rheumatol; 2008; 26(3):401-7. PubMed ID: 18578960
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of studies of productivity loss due to rheumatoid arthritis.
Burton W; Morrison A; Maclean R; Ruderman E
Occup Med (Lond); 2006 Jan; 56(1):18-27. PubMed ID: 16286432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
